Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis - Buonerba, C; Dolce, P; Iaccarino, S (Cancers (Basel), 2020)
et al.